16 results
8-K
EX-99.1
OCUP
Ocuphire Pharma Inc
27 Sep 23
RYZUMVI Expected to be Commercially Available in the U.S. in the First Half of 2024
8:45am
sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
that Ocuphire can realize its plans on the projected timetable in order to reach sustainable or profitable operations.
Ocuphire will need substantial additional
424B5
fq2xyhqt
7 Jun 21
Prospectus supplement for primary offering
4:21pm
424B5
r7w un4li
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
nxfit2u tvp
17 Feb 21
Prospectus supplement with pricing info
7:14am
424B3
vgmgu3z1grkyy
2 Oct 20
Prospectus supplement
9:25am
S-4/A
358aa7zsi3
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4
8q9q dn67lzoixs4
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
8-K
EX-99.1
m5zzif1zu6l41na8 fp2
11 Aug 05
Rexahn Pharmaceuticals Announces $9.65 Million Private Placement
12:00am
- Prev
- 1
- Next